Takara Bio (Germany) Analysis
| TF2 Stock | EUR 5.00 0.40 7.41% |
200 Day MA 4.5625 | 50 Day MA 4.08 | Beta 0.365 |
Takara Bio holds a debt-to-equity ratio of 0.016. The Takara Bio's current Long Term Debt is estimated to increase to about 123.8 M, while Short and Long Term Debt is projected to decrease to roughly 40.2 M. Takara Bio's financial risk is the risk to Takara Bio stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Takara Bio's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Takara Bio's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Takara Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Takara Bio's stakeholders.
For many companies, including Takara Bio, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Takara Bio, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Takara Bio's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 1.1522 | Enterprise Value Ebitda 209.857 | Price Sales 0.0147 | Shares Float 44.9 M | Dividend Share 17 |
Takara Bio is overvalued with Real Value of 5.17 and Hype Value of 6.02. The main objective of Takara Bio stock analysis is to determine its intrinsic value, which is an estimate of what Takara Bio is worth, separate from its market price. There are two main types of Takara Bio's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Takara Bio's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Takara Bio's stock to identify patterns and trends that may indicate its future price movements.
The Takara Bio stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Takara Bio's ongoing operational relationships across important fundamental and technical indicators.
Takara |
Takara Stock Analysis Notes
About 62.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.15. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Takara Bio recorded a loss per share of 0.29. The entity last dividend was issued on the 30th of March 2026. The firm had 400:1 split on the 29th of March 2011. Takara Bio Inc., together with its subsidiaries, operates as a biotechnology company in Japan, the United States, China, other Asia, Europe, and internationally. The company was founded in 2002 and is headquartered in Kusatsu, Japan. TAKARA BIO is traded on Frankfurt Stock Exchange in Germany. To find out more about Takara Bio contact Koichi Nakao at 81 77 565 6920 or learn more at https://www.takara-bio.com.Takara Bio Quarterly Total Revenue |
|
Takara Bio Investment Alerts
| Takara Bio had very high historical volatility over the last 90 days | |
| Takara Bio has high likelihood to experience some financial distress in the next 2 years | |
| About 62.0% of the company outstanding shares are owned by corporate insiders |
Takara Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 650.71 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Takara Bio's market, we take the total number of its shares issued and multiply it by Takara Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Takara Profitablity
Takara Bio's profitability indicators refer to fundamental financial ratios that showcase Takara Bio's ability to generate income relative to its revenue or operating costs. If, let's say, Takara Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Takara Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Takara Bio's profitability requires more research than a typical breakdown of Takara Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.26) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.26. Management Efficiency
At this time, Takara Bio's Intangible Assets are most likely to increase significantly in the upcoming years. The Takara Bio's current Non Currrent Assets Other is estimated to increase to about 1.8 B, while Total Assets are projected to decrease to roughly 97.1 B. Takara Bio's management efficiency ratios could be used to measure how well Takara Bio manages its routine affairs as well as how well it operates its assets and liabilities.Leadership effectiveness at Takara Bio is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 16th of February 2026, Takara Bio has the Coefficient Of Variation of 2620.87, semi deviation of 2.55, and Risk Adjusted Performance of 0.0388. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Takara Bio, as well as the relationship between them. Please validate Takara Bio jensen alpha, maximum drawdown, and the relationship between the information ratio and treynor ratio to decide if Takara Bio is priced more or less accurately, providing market reflects its prevalent price of 5.0 per share.Takara Bio Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Takara Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Takara Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Takara Bio Outstanding Bonds
Takara Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Takara Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Takara bonds can be classified according to their maturity, which is the date when Takara Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Takara Bio Predictive Daily Indicators
Takara Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Takara Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Takara Bio Forecast Models
Takara Bio's time-series forecasting models are one of many Takara Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Takara Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Takara Bio Debt to Cash Allocation
Many companies such as Takara Bio, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Takara Bio has accumulated 9.49 B in total debt with debt to equity ratio (D/E) of 0.02, which may suggest the company is not taking enough advantage from borrowing. Takara Bio has a current ratio of 3.23, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Takara Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Takara Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Takara Bio sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Takara to invest in growth at high rates of return. When we think about Takara Bio's use of debt, we should always consider it together with cash and equity.Takara Bio Total Assets Over Time
Takara Bio Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Takara Bio's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Takara Bio, which in turn will lower the firm's financial flexibility.Takara Bio Corporate Bonds Issued
Most Takara bonds can be classified according to their maturity, which is the date when Takara Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Takara Long Term Debt
Long Term Debt |
|
About Takara Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Takara Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Takara shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Takara Bio. By using and applying Takara Stock analysis, traders can create a robust methodology for identifying Takara entry and exit points for their positions.
Takara Bio Inc., together with its subsidiaries, operates as a biotechnology company in Japan, the United States, China, other Asia, Europe, and internationally. The company was founded in 2002 and is headquartered in Kusatsu, Japan. TAKARA BIO is traded on Frankfurt Stock Exchange in Germany.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Takara Bio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Complementary Tools for Takara Stock analysis
When running Takara Bio's price analysis, check to measure Takara Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takara Bio is operating at the current time. Most of Takara Bio's value examination focuses on studying past and present price action to predict the probability of Takara Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takara Bio's price. Additionally, you may evaluate how the addition of Takara Bio to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |